Gary is an analytical biochemist with approximately twenty-five years of experience in the biotech and pharma industries. He started his career at Amgen as a bench scientist, which progressed to product technical lead for development and commercial support of several large molecule products, including cytokine, glycoprotein and monoclonal antibody therapeutics. Prior to joining Neva in 2021, Gary worked as a consultant for four years with several virtual, medium and large company clients at various stages in the clinical development cycle to complete CMC-related analytical projects, while expanding his experience into vaccine, oligonucleotide and cellular therapy products. This work included evaluation, selection and technical oversight of contract testing laboratories for development and validation of biochemical and bioanalytical methods, development and execution of product characterization and/or comparability strategies, data interpretation and auditing, problem solving and troubleshooting, analytical method and technology transfer, and authoring of regulatory filings. Gary earned bachelor’s degrees in Biochemistry, and Molecular, Cellular and Developmental Biology (MCDB) from the University of Colorado-Boulder.